Bicycle Therapeutics Plc (BCYC)
3.73
+0.06
(+1.63%)
USD |
NASDAQ |
Nov 04, 13:58
Bicycle Therapeutics Price : 3.73 for Nov. 4, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 03, 2026 | 3.61 | 3.71 | 3.61 | 3.67 | 81555.00 |
| Nov 02, 2026 | 3.69 | 3.785 | 3.58 | 3.62 | 348236.0 |
| Oct 30, 2026 | 3.75 | 3.80 | 3.60 | 3.66 | 348588.0 |
| Oct 29, 2026 | 3.92 | 4.135 | 3.705 | 3.82 | 598173.0 |
| Oct 28, 2026 | 3.76 | 3.89 | 3.71 | 3.88 | 436243.0 |
| Oct 27, 2026 | 3.66 | 3.84 | 3.61 | 3.78 | 486230.0 |
| Oct 26, 2026 | 3.56 | 3.69 | 3.53 | 3.65 | 525955.0 |
| Oct 23, 2026 | 3.64 | 3.64 | 3.415 | 3.55 | 346808.0 |
| Oct 22, 2026 | 3.56 | 3.64 | 3.525 | 3.64 | 276237.0 |
| Oct 21, 2026 | 3.62 | 3.797 | 3.56 | 3.57 | 406404.0 |
| Oct 20, 2026 | 3.53 | 3.71 | 3.52 | 3.60 | 488210.0 |
| Oct 19, 2026 | 3.45 | 3.64 | 3.41 | 3.535 | 692063.0 |
| Oct 16, 2026 | 3.58 | 3.60 | 3.42 | 3.46 | 565604.0 |
| Oct 15, 2026 | 3.51 | 3.64 | 3.50 | 3.60 | 411543.0 |
| Oct 14, 2026 | 3.63 | 3.755 | 3.50 | 3.51 | 439358.0 |
| Oct 13, 2026 | 3.81 | 3.88 | 3.63 | 3.63 | 457219.0 |
| Oct 12, 2026 | 3.89 | 3.91 | 3.785 | 3.80 | 233483.0 |
| Oct 09, 2026 | 3.81 | 3.92 | 3.775 | 3.89 | 300616.0 |
| Oct 08, 2026 | 3.71 | 3.81 | 3.620 | 3.81 | 338684.0 |
| Oct 07, 2026 | 3.75 | 3.805 | 3.68 | 3.73 | 479627.0 |
| Oct 06, 2026 | 4.02 | 4.025 | 3.735 | 3.79 | 620680.0 |
| Oct 05, 2026 | 3.62 | 4.039 | 3.61 | 4.01 | 1.846M |
| Oct 02, 2026 | 3.65 | 3.695 | 3.330 | 3.38 | 728669.0 |
| Oct 01, 2026 | 3.67 | 3.74 | 3.55 | 3.56 | 379977.0 |
| Sep 30, 2026 | 3.69 | 3.77 | 3.66 | 3.68 | 295139.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Autolus Therapeutics Plc | 1.395 |
| DBV Technologies SA | 9.86 |
| Cellectis SA | 1.12 |
| Akari Therapeutics Plc | 9.01 |
| Biodexa Pharmaceuticals Plc | 2.79 |
Price Related Metrics
| PS Ratio | 3.116 |
| Price to Book Value | 0.5167 |
| Earnings Yield | -54.52% |
| Market Cap | 188.57M |